OOIR: Observatory of International Research

Papers

(The median citation count of JAMA Psychiatry is 5. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-09-01 to 2025-09-01.)

Article	Citations
Magnetic Seizure Therapy vs Electroconvulsive Therapy for Major Depressive Episode	773
Error in Results	538
Further Considerations on Early Intervention for Borderline Personality Disorder—Reply	448
Combination Antidepressant Therapy vs Monotherapy—Further Considerations	409
Potential Limitations for Assessing Adverse Posttraumatic Neuropsychiatric Sequelae With Wrist-Wearable Device and Self-report Survey	300
Assumptions and Limitations of the Synthetic Control Method	258
Managerial and Organizational Challenges in the Age of AI	249
An Opportunity to Advance Cannabis Science—DEA Rescheduling	238
JAMA Psychiatry	234
The Reliability of Traumatic and Adverse Experiences	211
Potential Lessons for DSM From Contemporary Philosophy of Science	198
Left Ventrolateral Prefrontal Cortical Activity During Reward Expectancy and Mania Risk	197
Association Between Genetic Risk for Psychiatric Disorders and the Probability of Living in Urban Settings	196
Race and Ethnicity of Editorial Board Members and Editors as an Indicator of Structural Racism in Psychiatry and Neuroscience Journals	185
Social Vulnerability and Prevalence and Treatment for Mental Health and Substance Use Disorders	183
Neighborhood Disadvantage and Autism Spectrum Disorder in a Population With Health Insurance	182
Consistency of Delusion Themes Across First and Subsequent Episodes of Psychosis	178
TikTok Challenges—Unintentional Injuries vs Suicide Attempts	159
Issues in Clinical Trial Design—Lessons From the FDA’s Rejection of MDMA	158
Effect of Culturally Tailored, Internet-Delivered Cognitive Behavioral Therapy for Insomnia in Black Women	151
JAMA Psychiatry	149
Diagnosing and Treating ADHD in Adults	147
Associations Between Objective and Subjective Experiences of Childhood Maltreatment and the Course of Emotional Disorders in Adulthood	143
Association of Comorbid Behavioral and Medical Conditions With Cannabis Use Disorder in Pregnancy	141
Associations Between Neuropsychiatric Symptoms and Neuropathological Diagnoses of Alzheimer Disease and Related Dementias	134

Accelerated Theta-Burst Stimulation for Treatment-Resistant Depression	130
Methamphetamine Use, Methamphetamine Use Disorder, and Associated Overdose Deaths Among US Adults	126
Percentage of Heavy Drinking Days Following Psilocybin-Assisted Psychotherapy vs Placebo in the Treatment of Adult Patients With Alcohol Use Disorder	118
JAMA Psychiatry	117
Effect of a Tobacco Cessation Intervention Incorporating Weight Management for Adults With Serious Mental Illness	113
JAMA Network Call for Papers on Health and the 2024 US Election	110
Errors in Figures 1 and 2	109
Living Alone and Drug Overdose Deaths in the US	109
Error in the Caption of Figures 2, 3, 4, and 5 and in Supplement 1	108
JAMA Psychiatry	107
Addiction Medicine Physicians and Medicinal Cannabinoids	104
US Veterans Affairs and Department of Defense 2023 Clinical Guideline for PTSD—Devolving Not Evolving	103
Searching the Brain for the Cause of Psychosis	103
Hyperalgesia in Patients With a History of Opioid Use Disorder	98
Association of Frailty With Risk of Suicide Attempt in a National Cohort of US Veterans Aged 65 Years or Older	95
Perinatal Mental Health Outcomes Following Natural Disasters	94
Mental Health Impairment and Outpatient Mental Health Care of US Children and Adolescents	93
The Role of Energy Homeostasis in Depression Pathophysiology and Its Heterogeneity	92
Risk for Mood, Anxiety, and Psychotic Disorders in Individuals at High and Low Genetic Liability for Bipolar Disorder and Major Depression	91
Error in Byline	90
Serotonin 4 Receptor Brain Binding in Major Depressive Disorder and Association With Memory Dysfunction	88
Efficacy of Augmentation of Cognitive Behavioral Therapy With Transcranial Direct Current Stimulation for Depression	87
Evaluation of Post–COVID-19 Cognitive Dysfunction: Recommendations for Researchers	86
Role of Polygenic Risk Score in the Familial Transmission of Bipolar Disorder in Youth	86
JAMA Psychiatry	84
COVID-19 and Mental Health in Young People—Causality or Co-occurrence?	83
JAMA Psychiatry—The Year in Review, 2021	82
Associating Violence With Schizophrenia—Risks and Biases—Reply	81
Errors in Figures 3, 4, and 5	81
Etiologic Studies of Premenstrual Disorders Require Prospective Confirmation of Affective Cyclicity	81
Expanding Current Approaches to Solve the Opioid Crisis	78
Comorbidity and Coaggregation of Major Depressive Disorder and Bipolar Disorder and Cannabis Use Disorder in a Controlled Family Study	74
Trends in Outpatient Psychotherapy Among Adults in the US	74
War Exposure and DNA Methylation in Syrian Refugee Children and Adolescents	74
Combination Antidepressant Therapy vs Monotherapy—Further Considerations	73
Limitations for Assessing Optimism and Physical Functioning in Women—Reply	73
JAMA Psychiatry	73
Does Vaccination Really Mitigate Psychiatric Implications of COVID-19?—Reply	72
Psychosis Spectrum Symptoms Before and After Adolescent Cannabis Use Initiation	71
Evaluation of a Model to Target High-risk Psychiatric Inpatients for an Intensive Postdischarge Suicide Prevention Intervention	71
Physician Suicide and Associated Features—What Defines a Physician?	69
Stratified Care vs Stepped Care for Depression	67
Adjuvant Psychotherapies to Prevent Relapse in Bipolar Disorder	67
Genetic Liabilities Differentiating Bipolar Disorder, Schizophrenia, and Major Depressive Disorder, and Phenotypic Heterogeneity in Bipolar Disorder	67
Methadone-Involved Overdose Deaths in the US Before and After Federal Policy Changes Expanding Take-Home Methadone Doses From Opioid Treatment Programs	66
Neurobiological, Psychosocial, and Behavioral Mechanisms Mediating Associations Between Physical Activity and Psychiatric Symptoms in Youth in the Netherlands	66
Social Determinants of Health and Suicide-Related Outcomes	65
Errors in Text, Tables, and Figure	65
Implementation Strategies Used and Reported in Brief Suicide Prevention Intervention Studies	65
Sweetened Beverages and Incident All-Cause Dementia Among Older Adults	65

Metabolomic Biomarker Signatures for Bipolar and Unipolar Depression	65
Errors in Author Affiliations, Table, and Figure 3	64
Error in Figure 2	62
Reducing the Risks of Nuclear War	62
Suicide Risk—A Specific Intervention Target	62
Etiologic Studies of Premenstrual Disorders Require Prospective Confirmation of Affective Cyclicity—Reply	60
Do Not Rule Out Double-blind Placebo Run-in Periods for Randomized Clinical Trials	60
Loss of PTSD Diagnosis in Response to Evidence-Based Treatments	60
Assessment of Disruptive Life Events for Individuals Diagnosed With Schizophrenia or Bipolar I Disorder Using Data From a Consumer Credit Reporting Agency	59
Psychomotor Slowing in Psychosis and Inhibitory Repetitive Transcranial Magnetic Stimulation	58
Rural and Urban Trends in Mental Health Readmissions	57
Efficacy and Cost-Benefit of Onsite Contraceptive Services With and Without Incentives Among Women With Opioid Use Disorder at High Risk for Unintended Pregnancy	57
The Need for Functional Assessments in School-Based Mental Health Intervention Research	56
Brexpiprazole and Sertraline Combination Treatment in Posttraumatic Stress Disorder	55
Written Exposure Therapy Finds Solid Footing Alongside First-Line Psychotherapies for Posttraumatic Stress Disorder	55
Right-Based Mental Health Care—Advantages of Tax-Financed Universal Mental Health Care	55
Emotional Experience of People With Schizophrenia and People at Risk for Psychosis	54
A Case for Permanent Adoption of Expanded Telehealth Services and Prescribing Flexibilities for Opioid Use Disorder	54
Bright Light Therapy as Add-On to Inpatient Treatment in Youth With Moderate to Severe Depression	53
Racial and Ethnic Disparities in Buprenorphine Treatment Duration in the US	53
Association Between Failures in Perceptual Updating and the Severity of Psychosis in Schizophrenia	52
Association of Receipt of Opioid Use Disorder–Related Telehealth Services and Medications for Opioid Use Disorder With Fatal Drug Overdoses Among Medicare Beneficiaries Before and During the COVID-19	52
Genetic and Phenotypic Features of Schizophrenia in the UK Biobank	52
Hospitalization Associated With Comorbid Psychiatric and Substance Use Disorders Among Adults With COVID-19 Treated in US Emergency Departments From April 2020 to August 2021	51
Baseline Antipsychotic Dose and Transition to Psychosis in Individuals at Clinical High Risk	50
The Rapid Rise in Investment in Psychedelics—Cart Before the Horse	50
Cognitive Behavior Therapy for Mental Disorders in Adults	49
Association of Racial Discrimination With Neural Response to Threat in Black Women in the US Exposed to Trauma	49
Brief Cognitive Behavioral Therapy for Suicidal Inpatients	49
Treating Bipolar Depression Using Psilocybin—Validity Threats Regarding Efficacy and Safety	48
Prospective and Retrospective Measures of Child Maltreatment and Their Association With Psychopathology	48
All-Cause and Cause-Specific Mortality Among Individuals With Hypochondriasis	48
Adverse Childhood Experiences and Mental Distress Among US Adults by Sexual Orientation	47
Association of Ambient Temperature With the Prevalence of Intimate Partner Violence Among Partnered Women in Low- and Middle-Income South Asian Countries	47
Lifetime Suicide Attempts in Otherwise Psychiatrically Healthy Individuals	47
Ultrarare Coding Variants and Cognitive Function in Schizophrenia	47
Effect of General Practitioner Training in a Collaborative Child Mental Health Care Program on Children’s Mental Health Outcomes in a Low-Resource Setting	45
Time to Treat the Climate and Nature Crisis as One Indivisible Global Health Emergency	45
JAMA Psychiatry	45
Error in Title of Figure 1	45
Errors in Byline and Abstract	45
Errors in Results and Tables	45
Sex Differences in Autism Heritability and Likelihood	45
Physician Suicide and Associated Features—What Defines a Physician?—Reply	44
Preexisting Neuropsychiatric Conditions and Associated Risk of Severe COVID-19 Infection and Other Acute Respiratory Infections	44
Transdisciplinary Science and Research Training in Psychiatry	43
Normative Modeling of Brain Morphometry in Clinical High Risk for Psychosis	43
Studying Harms Is Key to Improving Psychedelic-Assisted Therapy—Participants Call for Changes to Research Landscape	42
Integrated Nicotine Replacement and Behavioral Support to Reduce Smoking in Opioid Agonist Therapy	42
Genetic Liability to Posttraumatic Stress Disorder Symptoms and Its Association With Cardiometabolic and Respiratory Outcomes	42
VA/Department of Defense Clinical Practice Guideline for PTSD and ASD	42
JAMA Psychiatry—The Year in Review 2024	41
Suicidal Ideation and Suicide Attempts After Direct or Indirect Psychotherapy	40
JAMA Psychiatry	40
Toward 90-90-90 Goals for Global Mental Health	40
Acupuncture for Combat-Related Posttraumatic Stress Disorder	40
Characterizing Heterogeneity in Neuroimaging, Cognition, Clinical Symptoms, and Genetics Among Patients With Late-Life Depression	39
Striatal Activity to Reward Anticipation as a Moderator of the Association Between Early Behavioral Inhibition and Changes in Anxiety and Depressive Symptoms From Adolescence to Adulthood	39
Functional vs Structural Cortical Deficit Pattern Biomarkers for Major Depressive Disorder	39
The Course of General Cognitive Ability in Individuals With Psychotic Disorders	39
Combination Antidepressant Therapy vs Monotherapy—Further Considerations—Reply	38
Error in Figure 1	38
JAMA Psychiatry	38
Antipsychotic Monotherapy vs Polytherapy for Pneumonia Risk—Reply	38
Complex Interaction of Lithium With Kidney and Bone Health	38
Error in Figure	38
Considerations Regarding Antipsychotic Drug Prescriptions Among People With Dementia During the COVID-19 Pandemic	38
Potential of Control Conditions for Nonspecific Treatment-Effects in Noninferiority Trials—Reply	38
Psilocybin in Bipolar II Study Provides Preliminary Data on Safety	38
JAMA Psychiatry	38
Telehealth Mindfulness-Oriented Recovery Enhancement vs Usual Care in Individuals With Opioid Use Disorder and Pain	37
Brain Morphometry Normative Modeling—Omit Global Thickness—Reply	37
Informant Effect on Placebo Response in Mental Disorders—Reply	37
Functional Connectivity of the Nucleus Accumbens and Changes in Appetite in Patients With Depression	37
Effects of a Smartphone-Based Self-management Intervention for Individuals With Bipolar Disorder on Relapse, Symptom Burden, and Quality of Life	36
Understanding Placebo Mechanisms to Reduce Attrition in Psychiatric Trials	36
Investing in a Research Workforce With Personal Experience of Serious Mental Illness	36
Prescription Stimulant Prescribing, Nonmedical Use, and Shortages	36
Effect of Technology-Enhanced Screening in Addition to Standard Targeted Clinician Education on the Duration of Untreated Psychosis	36
Why Hippocampal Glutamate Levels Are Elevated in Schizophrenia	36

Associations Between Early Life Adversity, Reproduction-Oriented Life Strategy, and Borderline Personality Disorder	35
Written Exposure Therapy vs Prolonged Exposure Therapy in the Treatment of Posttraumatic Stress Disorder	35
Female Physician Suicide Compared to the General Population	35
Differences in Insurance Coverage for Individuals With Schizophrenia After Implementation of the Patient Protection and Affordable Care Act	35
Issues With Person-Time and Repetitive Event Calculation	35
Coding Error for the Sex Variable in a Meta-analysis	34
Mental Health Care Support in Rural India	34
COVID-19 and Risk for Mental Disorders Among Adults in Denmark	34
Substance Use Disorder and Health Outcomes in COVID-19—The Need for a Better Research Method to Determine Substance Use Exposure—Reply	34
RETRACTED: Dynamic Prediction of Outcomes for Youth at Clinical High Risk for Psychosis	34
Substance Use Disorder and Health Outcomes in COVID-19—The Need for a Better Research Method to Determine Substance Use Exposure	34
Association of Cardiovascular Health With Risk of Clinically Relevant Depressive Symptoms	34
Mental Health Treatment Gap—The Implementation Problem as a Research Problem	34
Change to Open Access Status	33
Posttraumatic Stress Disorder, Obesity, and Accelerated Epigenetic Aging Among US Military Veterans	33
COP27 Climate Change Conference—Urgent Action Needed for Africa and the World	33
Issues With Person-Time and Repetitive Event Calculation—Reply	32
Antipsychotic Acute-Phase Treatment in Individuals With and Without Recent Treatment	31
Reporting and Representation of Race and Ethnicity in Clinical Trials of Pharmacotherapy for Mental Disorders	31
Lessons Learned From Drug Decriminalization Remedies in British Columbia	31
Data-Driven Contingency Management Incentive Magnitudes	31
Depression Associated With Hormonal Contraceptive Use as a Risk Indicator for Postpartum Depression	30
Preaddiction—A Missing Concept for Treating Substance Use Disorders	30
Transcriptome-Wide Structural Equation Modeling of 13 Major Psychiatric Disorders for Cross-Disorder Risk and Drug Repurposing	30
Estimated Number of Children Who Lost a Parent to Drug Overdose in the US From 2011 to 2021	30
International Variation in Clozapine Hematologic Monitoring—A Call for Action	30
Alcohol Cue Processing in Co-Occurring Bipolar Disorder and Alcohol Use Disorder	30
Timing of Antidepressant Discontinuation During Pregnancy and Postpartum Psychiatric Outcomes in Denmark and Norway	30
Effectiveness of Standard Sequential Bilateral Repetitive Transcranial Magnetic Stimulation vs Bilateral Theta Burst Stimulation in Older Adults With Depression	29
Association of 24-Hour Activity Pattern Phenotypes With Depression Symptoms and Cognitive Performance in Aging	29
Patterns of Brain Maturation in Autism and Their Molecular Associations	29
Interaction Testing and Polygenic Risk Scoring to Estimate the Association of Common Genetic Variants With Treatment Resistance in Schizophrenia	29
Inflammatory Exposure and Depression in Older Adults With Insomnia	29
Representation and Outcomes of Individuals With Schizophrenia Seen in Everyday Practice Who Are Ineligible for Randomized Clinical Trials	29
Long-term Arrhythmia Detection Using an Implantable Loop Recorder in Patients Receiving Psychotropic Medication	28
Association of Brain Reward Response With Body Mass Index and Ventral Striatal-Hypothalamic Circuitry Among Young Women With Eating Disorders	28
Distinct Convergent Brain Alterations in Sleep Disorders and Sleep Deprivation	28
Inflammation and Brain Structure in Schizophrenia and Other Neuropsychiatric Disorders	28
Association of Oxidative Stress–Induced Nucleic Acid Damage With Psychiatric Disorders in Adults	28
Dissimilar Control Interventions in Clinical Trials Undermine Interpretability—Reply	27
JAMA Psychiatry Editorial Fellow	27
JAMA Psychiatry Peer Reviewers in 2021	27
Mental Health Service Use Before First Diagnosis of a Psychotic Disorder	27
Error in Results and in the Figure 3B Label and Plotted Values	27
JAMA Psychiatry Editorial Fellow	27
Value-Based Payment and Behavioral Health	26
Treatment Outcomes With Licensed and Unlicensed Stimulant Doses for Adults With Attention-Deficit/Hyperactivity Disorder	26
Notice of Retraction: Worthington MA et al. Dynamic Prediction of Outcomes for Youth at Clinical High Risk for Psychosis: A Joint Modeling Approach. JAMA Psychiatry. 2023;80(10):1017-1025.	26
Neuropsychiatric Ramifications of Severe COVID-19 and Other Severe Acute Respiratory Infections	26
Cognitive Function in People With Familial Risk of Depression	26
Evolutionary Inquiries Into the Origin and Nature of Mental Disorders	26
Suicidality Calls to a National Helpline After a Terror Attack and War	26
Psychopharmacologic Considerations for Transgender and Gender Diverse People	26
Clinician Suicide Risk Assessment for Prediction of Suicide Attempt in a Large Health Care System	25
Clinical Outcomes of Magnetic Seizure Therapy vs Electroconvulsive Therapy for Major Depressive Episode	25
Prevention of Incident and Recurrent Major Depression in Older Adults With Insomnia	25
Antipsychotic Medications and Mortality in Children and Young Adults	25
Maintenance of Wellness in Patients With Obsessive-Compulsive Disorder Who Discontinue Medication After Exposure/Response Prevention Augmentation	25
An Atlas of Genetic Correlations and Genetically Informed Associations Linking Psychiatric and Immune-Related Phenotypes	25
Penetrance and Pleiotropy of Polygenic Risk Scores for Schizophrenia, Bipolar Disorder, and Depression Among Adults in the US Veterans Affairs Health Care System	24
Association Between Physical Activity and Risk of Depression	24
Error in Figure 2	24
Social Disconnection as a Global Behavioral Epidemic—A Call to Action About a Major Health Risk Factor	24
Errors in Network Meta-Analysis of Generalized Anxiety Disorder Psychotherapies	24
Change to Open Access Status	24
JAMA Psychiatry	24
Antidepressant Use and Manic Episodes in Children and Adolescents With Unipolar Depression	23
Grief-Specific Cognitive Behavioral Therapy vs Present-Centered Therapy	23
Promoting Social Prescribing in Psychiatry—Using Shared Decision-Making and Peer Support	23
SSRIs in Pregnancy—What Offspring Brain Volumes Can and Cannot Tell Us—Reply	23
Error in Display of Author Name	23
Ten Practical Recommendations for Improving Blinding Integrity and Reporting in Psychotherapy Trials	23
Climate Events, Displacement, and Mental Health—Uprooted	23
Error in Figure Caption	23
Years of Life Lost to Drug Overdose Among Black Female Individuals in the US, 2015-2021	23
Anorexia Nervosa—Facts, Frustrations, and the Future	23
National Data on Age Gradients in Well-being Among US Adults	22
Gratitude and Mortality Among Older US Female Nurses	22
Polygenic Risk Scores Derived From Varying Definitions of Depression and Risk of Depression	22
Sleep Abnormalities in Different Clinical Stages of Psychosis	22
Potential of Control Conditions for Nonspecific Treatment Effects in Noninferiority Trials	22
Addressing the Escalating Problems That Patients Encounter When Filling Buprenorphine Prescriptions	22
Preliminary Research Priorities for Factors Influencing Individual Outcomes for Users of the US National Suicide Prevention Lifeline	22
Esketamine Combined With SSRI or SNRI for Treatment-Resistant Depression	22
Transmission of Mental Disorders in Adolescent Peer Networks	22
Efficacy of Adjunctive D-Cycloserine to Intermittent Theta-Burst Stimulation for Major Depressive Disorder	22
Association of Alcohol With Cortical Thickness in Adolescents	22
Beyond Voluntariness—Ethics and Incentives for Contraception	21
Efficacy and Safety of Antidepressants in Patients With Comorbid Depression and Medical Diseases	21
Errors in Data Reported in Meta-Analysis on Opioid Agonist Treatment and Mortality	21
Overcoming the Scourge of Missing Data in Psychotherapy Trials	21
Error in Results	21
Author Name Change	21
Mass Violence and the Complex Spectrum of Mental Illness and Mental Functioning	21
Genetic Confounding in the Association Between Traumatic Brain Injury and Mental Disorder or Suicide	20